HER-2 Targeted Drugs for Breast Cancer Market Report

China HER-2 Targeted Drugs for Breast Cancer Industry Market Research Report 2023-2029

  • POSTDATE：Oct 11, 2023
  • PAGES：160
  • REPORT CODE：GMM1844471
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the HER-2 Targeted Drugs for Breast Cancer industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • GlaxoSmithKline

    • CANbridge

    • Pfizer

    • Chugai Pharmaceutical

    • Hengrui Medicine

    • Beacon Pharmaceuticals Limited

    • Novartis

    • Puma Biotechnology

    • Roche

    By Type:

    • Neratinib

    • Lapatinib

    • Trastuzumab

    • Pyrotinib

    • Pertuzumab

    • Other

    • Trastuzumab Emtansine

    By Application:

    • Drug Center

    • Other

    • Hospital

    • Clinic

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China HER-2 Targeted Drugs for Breast Cancer Market Overview 2018-2029

    • 1.1 China HER-2 Targeted Drugs for Breast Cancer Industry Development Overview

    • 1.2 China HER-2 Targeted Drugs for Breast Cancer Industry Development History

    • 1.3 China HER-2 Targeted Drugs for Breast Cancer Industry Market Size (2018-2029)

    • 1.4 China HER-2 Targeted Drugs for Breast Cancer Market Analysis by Type from Production Side

      • 1.4.1 China HER-2 Targeted Drugs for Breast Cancer Production Volume, Production Value and Growth Rate of Neratinib (2018-2029)

      • 1.4.2 China HER-2 Targeted Drugs for Breast Cancer Production Volume, Production Value and Growth Rate of Lapatinib (2018-2029)

      • 1.4.3 China HER-2 Targeted Drugs for Breast Cancer Production Volume, Production Value and Growth Rate of Trastuzumab (2018-2029)

      • 1.4.4 China HER-2 Targeted Drugs for Breast Cancer Production Volume, Production Value and Growth Rate of Pyrotinib (2018-2029)

      • 1.4.5 China HER-2 Targeted Drugs for Breast Cancer Production Volume, Production Value and Growth Rate of Pertuzumab (2018-2029)

      • 1.4.6 China HER-2 Targeted Drugs for Breast Cancer Production Volume, Production Value and Growth Rate of Other (2018-2029)

      • 1.4.7 China HER-2 Targeted Drugs for Breast Cancer Production Volume, Production Value and Growth Rate of Trastuzumab Emtansine (2018-2029)

    • 1.5 China HER-2 Targeted Drugs for Breast Cancer Market Analysis by Application from Consumption End

      • 1.5.1 China HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate of Drug Center (2018-2029)

      • 1.5.2 China HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.3 China HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.4 China HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • 1.6 China HER-2 Targeted Drugs for Breast Cancer Market Analysis by Region

      • 1.6.1 North China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate from 2018-2029

    Chapter 2 China HER-2 Targeted Drugs for Breast Cancer Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on HER-2 Targeted Drugs for Breast Cancer Market Status and Competition at home and abroad in 2023

      • 2.2.2 China HER-2 Targeted Drugs for Breast Cancer Market Status and Competition Analysis in 2023

      • 2.2.3 China HER-2 Targeted Drugs for Breast Cancer Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China HER-2 Targeted Drugs for Breast Cancer Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on HER-2 Targeted Drugs for Breast Cancer Industry Development

    Chapter 3 HER-2 Targeted Drugs for Breast CancerIndustry Chain Analysis

    • 3.1 HER-2 Targeted Drugs for Breast Cancer Industry Chain

    • 3.2 HER-2 Targeted Drugs for Breast Cancer Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the HER-2 Targeted Drugs for Breast Cancer Market

    • 3.3 HER-2 Targeted Drugs for Breast Cancer Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the HER-2 Targeted Drugs for Breast Cancer Market

    Chapter 4 China HER-2 Targeted Drugs for Breast Cancer Market, by Type

    • 4.1 China HER-2 Targeted Drugs for Breast Cancer Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China HER-2 Targeted Drugs for Breast Cancer Total Production Volume and Growth Rate from Production Side

    • 4.5 China HER-2 Targeted Drugs for Breast Cancer Production Volume and Growth Rate, by Type

      • 4.5.1 China HER-2 Targeted Drugs for Breast Cancer Production Volume and Growth Rate of Neratinib

      • 4.5.2 China HER-2 Targeted Drugs for Breast Cancer Production Volume and Growth Rate of Lapatinib

      • 4.5.3 China HER-2 Targeted Drugs for Breast Cancer Production Volume and Growth Rate of Trastuzumab

      • 4.5.4 China HER-2 Targeted Drugs for Breast Cancer Production Volume and Growth Rate of Pyrotinib

      • 4.5.5 China HER-2 Targeted Drugs for Breast Cancer Production Volume and Growth Rate of Pertuzumab

      • 4.5.6 China HER-2 Targeted Drugs for Breast Cancer Production Volume and Growth Rate of Other

      • 4.5.7 China HER-2 Targeted Drugs for Breast Cancer Production Volume and Growth Rate of Trastuzumab Emtansine

    Chapter 5 China HER-2 Targeted Drugs for Breast Cancer Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China HER-2 Targeted Drugs for Breast Cancer Total Market Size and Growth Rate from Consumption End

    • 5.5 China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate, by Application

      • 5.5.1 China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Drug Center

      • 5.5.2 China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Other

      • 5.5.3 China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Hospital

      • 5.5.4 China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Clinic

    Chapter 6 China HER-2 Targeted Drugs for Breast Cancer Market, by Region

    • 6.1 China HER-2 Targeted Drugs for Breast Cancer Production Volume and Production Value, by Region

    • 6.2 China HER-2 Targeted Drugs for Breast Cancer Sales Volume and Sales Value, by Region

    Chapter 7 North China HER-2 Targeted Drugs for Breast Cancer Market Analysis

    • 7.1 North China HER-2 Targeted Drugs for Breast Cancer Market, by Type

    • 7.2 North China HER-2 Targeted Drugs for Breast Cancer Market, by Application

    Chapter 8 Central China HER-2 Targeted Drugs for Breast Cancer Market Analysis

    • 8.1 Central China HER-2 Targeted Drugs for Breast Cancer Market, by Type

    • 8.2 Central China HER-2 Targeted Drugs for Breast Cancer Market, by Application

    Chapter 9 South China HER-2 Targeted Drugs for Breast Cancer Market Analysis

    • 9.1 South China HER-2 Targeted Drugs for Breast Cancer Market, by Type

    • 9.2 South China HER-2 Targeted Drugs for Breast Cancer Market, by Application

    Chapter 10 East China HER-2 Targeted Drugs for Breast Cancer Market Analysis

    • 10.1 East China HER-2 Targeted Drugs for Breast Cancer Market, by Type

    • 10.2 East China HER-2 Targeted Drugs for Breast Cancer Market, by Application

    Chapter 11 Northeast China HER-2 Targeted Drugs for Breast Cancer Market Analysis

    • 11.1 Northeast China HER-2 Targeted Drugs for Breast Cancer Market, by Type

    • 11.2 Northeast China HER-2 Targeted Drugs for Breast Cancer Market, by Application

    Chapter 12 Southwest China HER-2 Targeted Drugs for Breast Cancer Market Analysis

    • 12.1 Southwest China HER-2 Targeted Drugs for Breast Cancer Market, by Type

    • 12.2 Southwest China HER-2 Targeted Drugs for Breast Cancer Market, by Application

    Chapter 13 Northwest China HER-2 Targeted Drugs for Breast Cancer Market Analysis

    • 13.1 Northwest China HER-2 Targeted Drugs for Breast Cancer Market, by Type

    • 13.2 Northwest China HER-2 Targeted Drugs for Breast Cancer Market, by Application

    Chapter 14 Company Profiles

      • 14.1 GlaxoSmithKline

        • 14.1.1 GlaxoSmithKline Company Profile

        • 14.1.2 GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 CANbridge

        • 14.2.1 CANbridge Company Profile

        • 14.2.2 CANbridge HER-2 Targeted Drugs for Breast Cancer Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Pfizer

        • 14.3.1 Pfizer Company Profile

        • 14.3.2 Pfizer HER-2 Targeted Drugs for Breast Cancer Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Chugai Pharmaceutical

        • 14.4.1 Chugai Pharmaceutical Company Profile

        • 14.4.2 Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Hengrui Medicine

        • 14.5.1 Hengrui Medicine Company Profile

        • 14.5.2 Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Beacon Pharmaceuticals Limited

        • 14.6.1 Beacon Pharmaceuticals Limited Company Profile

        • 14.6.2 Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Novartis

        • 14.7.1 Novartis Company Profile

        • 14.7.2 Novartis HER-2 Targeted Drugs for Breast Cancer Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Puma Biotechnology

        • 14.8.1 Puma Biotechnology Company Profile

        • 14.8.2 Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Roche

        • 14.9.1 Roche Company Profile

        • 14.9.2 Roche HER-2 Targeted Drugs for Breast Cancer Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 HER-2 Targeted Drugs for Breast Cancer Industry Research Conclusions

    • 15.2 HER-2 Targeted Drugs for Breast Cancer Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China HER-2 Targeted Drugs for Breast Cancer Industry Market Size (2018-2029)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Volume, Production Value and Growth Rate of Neratinib (2018-2029)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Volume, Production Value and Growth Rate of Lapatinib (2018-2029)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Volume, Production Value and Growth Rate of Trastuzumab (2018-2029)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Volume, Production Value and Growth Rate of Pyrotinib (2018-2029)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Volume, Production Value and Growth Rate of Pertuzumab (2018-2029)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Volume, Production Value and Growth Rate of Trastuzumab Emtansine (2018-2029)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate of Drug Center (2018-2029)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure North China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate from 2018-2029

    • Figure Central China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate from 2018-2029

    • Figure South China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate from 2018-2029

    • Figure East China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate from 2018-2029

    • Figure Northeast China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate from 2018-2029

    • Figure Southwest China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate from 2018-2029

    • Figure Northwest China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate from 2018-2029

    • Figure HER-2 Targeted Drugs for Breast Cancer Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China HER-2 Targeted Drugs for Breast Cancer Market Share by Type in 2018

    • Figure China HER-2 Targeted Drugs for Breast Cancer Market Share by Type in 2023

    • Figure China HER-2 Targeted Drugs for Breast Cancer Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Volume and Growth Rate of Neratinib (2018-2023)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Volume and Growth Rate of Lapatinib (2018-2023)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Volume and Growth Rate of Trastuzumab (2018-2023)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Volume and Growth Rate of Pyrotinib (2018-2023)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Volume and Growth Rate of Pertuzumab (2018-2023)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Volume and Growth Rate of Other (2018-2023)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Volume and Growth Rate of Trastuzumab Emtansine (2018-2023)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Market Share by Application in 2018

    • Figure China HER-2 Targeted Drugs for Breast Cancer Market Share by Application in 2023

    • Figure China HER-2 Targeted Drugs for Breast Cancer Total Market Size and Growth Rate from Consumption End

    • Figure China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Drug Center (2018-2023)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Other (2018-2023)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Clinic (2018-2023)

    • Table China HER-2 Targeted Drugs for Breast Cancer Production Volume by Region (2018-2023)

    • Table China HER-2 Targeted Drugs for Breast Cancer Production Volume Share by Region (2018-2023)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Volume Share by Region (2018-2023)

    • Table China HER-2 Targeted Drugs for Breast Cancer Production Value by Region (2018-2023)

    • Table China HER-2 Targeted Drugs for Breast Cancer Production Value Share by Region (2018-2023)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Value Share by Region (2018-2023)

    • Table China HER-2 Targeted Drugs for Breast Cancer Sales Volume by Region (2018-2023)

    • Table China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share by Region (2018-2023)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share by Region (2018-2023)

    • Table China HER-2 Targeted Drugs for Breast Cancer Sales Value by Region (2018-2023)

    • Table China HER-2 Targeted Drugs for Breast Cancer Sales Value Share by Region (2018-2023)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Sales Value Share by Region (2018-2023)

    • Table North China HER-2 Targeted Drugs for Breast Cancer Production Volume by Type (2018-2023)

    • Table North China HER-2 Targeted Drugs for Breast Cancer Production Volume Share by Type (2018-2023)

    • Figure North China HER-2 Targeted Drugs for Breast Cancer Production Volume Share by Type (2018-2023)

    • Table North China HER-2 Targeted Drugs for Breast Cancer Sales Volume by Application (2018-2023)

    • Table North China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share by Application (2018-2023)

    • Figure North China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share by Application (2018-2023)

    • Table Central China HER-2 Targeted Drugs for Breast Cancer Production Volume by Type (2018-2023)

    • Table Central China HER-2 Targeted Drugs for Breast Cancer Production Volume Share by Type (2018-2023)

    • Figure Central China HER-2 Targeted Drugs for Breast Cancer Production Volume Share by Type (2018-2023)

    • Table Central China HER-2 Targeted Drugs for Breast Cancer Sales Volume by Application (2018-2023)

    • Table Central China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share by Application (2018-2023)

    • Figure Central China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share by Application (2018-2023)

    • Table South China HER-2 Targeted Drugs for Breast Cancer Production Volume by Type (2018-2023)

    • Table South China HER-2 Targeted Drugs for Breast Cancer Production Volume Share by Type (2018-2023)

    • Figure South China HER-2 Targeted Drugs for Breast Cancer Production Volume Share by Type (2018-2023)

    • Table South China HER-2 Targeted Drugs for Breast Cancer Sales Volume by Application (2018-2023)

    • Table South China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share by Application (2018-2023)

    • Figure South China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share by Application (2018-2023)

    • Table East China HER-2 Targeted Drugs for Breast Cancer Production Volume by Type (2018-2023)

    • Table East China HER-2 Targeted Drugs for Breast Cancer Production Volume Share by Type (2018-2023)

    • Figure East China HER-2 Targeted Drugs for Breast Cancer Production Volume Share by Type (2018-2023)

    • Table East China HER-2 Targeted Drugs for Breast Cancer Sales Volume by Application (2018-2023)

    • Table East China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share by Application (2018-2023)

    • Figure East China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share by Application (2018-2023)

    • Table Northeast China HER-2 Targeted Drugs for Breast Cancer Production Volume by Type (2018-2023)

    • Table Northeast China HER-2 Targeted Drugs for Breast Cancer Production Volume Share by Type (2018-2023)

    • Figure Northeast China HER-2 Targeted Drugs for Breast Cancer Production Volume Share by Type (2018-2023)

    • Table Northeast China HER-2 Targeted Drugs for Breast Cancer Sales Volume by Application (2018-2023)

    • Table Northeast China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share by Application (2018-2023)

    • Figure Northeast China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share by Application (2018-2023)

    • Table Southwest China HER-2 Targeted Drugs for Breast Cancer Production Volume by Type (2018-2023)

    • Table Southwest China HER-2 Targeted Drugs for Breast Cancer Production Volume Share by Type (2018-2023)

    • Figure Southwest China HER-2 Targeted Drugs for Breast Cancer Production Volume Share by Type (2018-2023)

    • Table Southwest China HER-2 Targeted Drugs for Breast Cancer Sales Volume by Application (2018-2023)

    • Table Southwest China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share by Application (2018-2023)

    • Figure Southwest China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share by Application (2018-2023)

    • Table Northwest China HER-2 Targeted Drugs for Breast Cancer Production Volume by Type (2018-2023)

    • Table Northwest China HER-2 Targeted Drugs for Breast Cancer Production Volume Share by Type (2018-2023)

    • Figure Northwest China HER-2 Targeted Drugs for Breast Cancer Production Volume Share by Type (2018-2023)

    • Table Northwest China HER-2 Targeted Drugs for Breast Cancer Sales Volume by Application (2018-2023)

    • Table Northwest China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share by Application (2018-2023)

    • Figure Northwest China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share by Application (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Revenue, Price and Gross (2018-2023)

    • Table CANbridge Company Profile

    • Table CANbridge HER-2 Targeted Drugs for Breast Cancer Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer HER-2 Targeted Drugs for Breast Cancer Revenue, Price and Gross (2018-2023)

    • Table Chugai Pharmaceutical Company Profile

    • Table Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Revenue, Price and Gross (2018-2023)

    • Table Hengrui Medicine Company Profile

    • Table Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Revenue, Price and Gross (2018-2023)

    • Table Beacon Pharmaceuticals Limited Company Profile

    • Table Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis HER-2 Targeted Drugs for Breast Cancer Revenue, Price and Gross (2018-2023)

    • Table Puma Biotechnology Company Profile

    • Table Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche HER-2 Targeted Drugs for Breast Cancer Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US